The NSD3L histone methyltransferase regulates cell cycle and cell invasion in breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 398, Issue 3, 2010, Pages 565-570

  Zhou, Zhangle ^a   Thomsen, Rune ^a   Kahns, Søren ^a   Nielsen, Anders Lade ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Carcinogenesis; Cell cycle; Epigenetics; Histone methyltransferase; Metastasis; NSD3; WHSC1L1

Indexed keywords

CELL CYCLE PROTEIN; HISTONE METHYLTRANSFERASE; NSD3L HISTONE METHYLTRANSFERASE; PROTEIN ARL2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; LEUKEMIA; LUNG CARCINOMA; METASTASIS; MICROARRAY ANALYSIS; NSD3 GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS;

EID: 77955268518     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.119     Document Type: Article

References (19)

1. Huang N., Vom baur E., Garnier J.M., Lerouge T., Vonesch J.L., Lutz Y., Chambon P., Losson R. Two distinct nuclear receptor interaction domains in NSD1, A novel SET protein that exhibits characteristics of both corepressors and coactivators. Embo J. 1998, 17:3398-3412.
2. Angrand P.O., Apiou F., Stewart A.F., Dutrillaux B., Losson R., Chambon P. NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines. Genomics 2001, 74:79-88.
3. Rosati R., La Starza R., Veronese A., Aventin A., Schwienbacher C., Vallespi T., Negrini M., Martelli M.F., Mecucci C. NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood 2002, 99:3857-3860.
4. Tonon G., Wong K.K., Maulik G., Brennan C., Feng B., Zhang Y., Khatry D.B., Protopopov A., You M.J., Aguirre A.J., Martin E.S., Yang Z., Ji H., Chin L., Depinho R.A. High-resolution genomic profiles of human lung cancer. Proc. Natl. Acad. Sci. USA 2005, 102:9625-9630.
5. Taketani T., Taki T., Nakamura H., Taniwaki M., Masuda J., Hayashi Y. NUP98-NSD3 fusion gene in radiation-associated myelodysplastic syndrome with t(8;11)(p11;p15) and expression pattern of NSD family genes. Cancer Genet Cytogenet 2009, 190:108-112.
6. Guffanti A., Iacono M., Pelucchi P., Kim N., Solda G., Croft L.J., Taft R.J., Rizzi E., Askarian-Amiri M., Bonnal R.J., Callari M., Mignone F., Pesole G., Bertalot G., Bernardi L.R., Albertini A., Lee C., Mattick J.S., Zucchi I., De Bellis G. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 2009, 10:163.
7. Stec I., van Ommen G.J., den Dunnen J.T. WHSC1L1, on human chromosome 8p11.2, closely resembles WHSC1 and maps to a duplicated region shared with 4p16.3. Genomics 2001, 76:5-8.
8. Bernard-Pierrot I., Gruel N., Stransky N., Vincent-Salomon A., Reyal F., Raynal V., Vallot C., Pierron G., Radvanyi F., Delattre O. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, A phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res. 2008, 68:7165-7175.
9. Kim S.M., Kee H.J., Choe N., Kim J.Y., Kook H., Kook H., Seo S.B. The histone methyltransferase activity of WHISTLE is important for the induction of apoptosis and HDAC1-mediated transcriptional repression. Exp. Cell Res. 2007, 313:975-983.
10. Kim S.M., Kee H.J., Eom G.H., Choe N.W., Kim J.Y., Kim Y.S., Kim S.K., Kook H., Kook H., Seo S.B. Characterization of a novel WHSC1-associated SET domain protein with H3K4 and H3K27 methyltransferase activity. Biochem. Biophys. Res. Commun. 2006, 345:318-323.
11. Douglas J., Coleman K., Tatton-Brown K., Hughes H.E., Temple I.K., Cole T.R., Rahman N. Evaluation of NSD2 and NSD3 in overgrowth syndromes. Eur. J. Hum. Genet. 2005, 13:150-153.
12. Vindelov L.L., Christensen I.J., Nissen N.I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983, 3:323-327.
13. Kamath L., Meydani A., Foss F., Kuliopulos A. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res. 2001, 61:5933-5940.
14. Hosack D.A., Dennis G., Sherman B.T., Lane H.C., Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003, 4:R70.
15. Draghici S., Khatri P., Martins R.P., Ostermeier G.C., Krawetz S.A. Global functional profiling of gene expression. Genomics 2003, 81:98-104.
16. Chaussepied M., Ginsberg D. E2F and signal transduction pathways. Cell Cycle 2005, 4:392-396.
17. Golias C.H., Charalabopoulos A., Charalabopoulos K. Cell proliferation and cell cycle control: a mini review. Int. J. Clin. Pract. 2004, 58:1134-1141.
18. DeGregori J., Johnson D.G. Distinct and overlapping roles for E2F family members in transcription proliferation and apoptosis. Curr. Mol. Med. 2006, 6:739-748.
19. Kedrin D., van Rheenen J., Hernandez L., Condeelis J., Segall J.E. Cell motility and cytoskeletal regulation in invasion and metastasis. J. Mammary Gland Biol. Neoplasia 2007, 12:143-152.